These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19347724)

  • 1. Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating.
    Carson KR; Bennett CL
    Leuk Lymphoma; 2009 Mar; 50(3):323-4. PubMed ID: 19347724
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune checkpoint blockade for treating progressive multifocal leukoencephalopathy.
    Hohlfeld R
    Lancet Neurol; 2019 Jul; 18(7):623-624. PubMed ID: 31104991
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular targeted therapy and progressive multifocal leukoencephalopathy].
    Takao M
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():869-76. PubMed ID: 26480807
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy: rituximab and PML risk-informed decisions needed!
    Calabrese LH; Molloy ES
    Nat Rev Rheumatol; 2009 Oct; 5(10):528-9. PubMed ID: 19798025
    [No Abstract]   [Full Text] [Related]  

  • 5. Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab.
    Tuccori M; Focosi D; Maggi F; Cosottini M; Meini B; Lena F; Blandizzi C; Del Tacca M; Petrini M
    Ann Hematol; 2010 May; 89(5):519-22. PubMed ID: 19727726
    [No Abstract]   [Full Text] [Related]  

  • 6. Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease.
    Calabrese LH; Molloy ES; Huang D; Ransohoff RM
    Arthritis Rheum; 2007 Jul; 56(7):2116-28. PubMed ID: 17599729
    [No Abstract]   [Full Text] [Related]  

  • 7. Progressive multifocal leukoencephalopathy in refractory polymyositis treated with rituximab.
    Marie I; Guegan-Massardier E; Levesque H
    Eur J Intern Med; 2011 Jun; 22(3):e13-4. PubMed ID: 21570627
    [No Abstract]   [Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma.
    Kranick SM; Mowry EM; Rosenfeld MR
    Neurology; 2007 Aug; 69(7):704-6. PubMed ID: 17698796
    [No Abstract]   [Full Text] [Related]  

  • 9. Progressive multifocal leukoencephalopathy in a patient with follicular lymphoma treated with multiple courses of rituximab.
    Reddy N; Abel TW; Jagasia M; Morgan D; Weaver K; Greer J
    Leuk Lymphoma; 2009 Mar; 50(3):460-2. PubMed ID: 19266387
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibody therapy and progressive multifocal leukoencephalopathy.
    Jackson AC
    Can J Neurol Sci; 2011 Jul; 38(4):545-6. PubMed ID: 21672693
    [No Abstract]   [Full Text] [Related]  

  • 11. Progressive multifocal leukoencephalopathy after rituximab in a patient with relapsed follicular lymphoma and low IgG levels and a low CD4+ lymphocyte count.
    Hopfinger G; Plessl A; Grisold W; Klimpfinger M; Höftberger R; Bernt R; Möstl M; Waldner R; Pittermann-Höcker E
    Leuk Lymphoma; 2008 Dec; 49(12):2367-9. PubMed ID: 19052987
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.
    Paues J; Vrethem M
    J Clin Virol; 2010 Aug; 48(4):291-3. PubMed ID: 20558102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progressive multifocal encephalopathy in a LED patient].
    Tikkakoski T; Ingo S; Julin L; Kanckos S
    Duodecim; 2015; 131(10):950-3. PubMed ID: 26237874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Targeted therapy and progressive multifocal leukoencephalopathy (PML): PML in the era of monoclonal antibody therapies].
    Takao M
    Brain Nerve; 2013 Nov; 65(11):1363-74. PubMed ID: 24200614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
    Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R
    Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive multifocal leucoencephalopathy in a patient with systemic lupus erythematosus treated with rituximab.
    Harris HE
    Rheumatology (Oxford); 2008 Feb; 47(2):224-5. PubMed ID: 18045807
    [No Abstract]   [Full Text] [Related]  

  • 17. Natalizumab and PML.
    Ransohoff RM
    Nat Neurosci; 2005 Oct; 8(10):1275. PubMed ID: 16189528
    [No Abstract]   [Full Text] [Related]  

  • 18. Atypical progressive multifocal leukoencephalopathy in a patient with antisynthetase syndrome.
    Belhassen-Garcia M; Rábano-Gutiérrez A; Velasco-Tirado V; Romero-Alegria A; Pérez-Garcia ML; Martin-Oterino JA
    Intern Med; 2015; 54(5):519-24. PubMed ID: 25758081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.
    Steurer M; Clausen J; Gotwald T; Gunsilius E; Stockhammer G; Gastl G; Nachbaur D
    Transplantation; 2003 Jul; 76(2):435-6. PubMed ID: 12883208
    [No Abstract]   [Full Text] [Related]  

  • 20. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
    Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
    Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.